Want to join the conversation?
$AGN's Generics' R&D team has submitted 25 new ANDAs in the US in 2015, with 16 of them potential first to files. The team is on track to submit approx. 35 applications by year-end. Outside the US, $AGN filed over 1,000 marketing authorizations in critical markets.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.